We are live on ! Find out more
BFA

BlackRock Fund Advisors Portfolio holdings

AUM $542B
1-Year Est. Return 18.13%
This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+18.13%
3 Year Est. Return
+41.39%
5 Year Est. Return
10 Year Est. Return
AUM
$542B
AUM Growth
+$55.1B
Cap. Flow
+$36.6B
Cap. Flow %
6.74%
Top 10 Hldgs %
9.63%
Holding
4,347
New
61
Increased
3,508
Reduced
323
Closed
93

Sector Composition

Rank Sector Weight
1 Financials 14.59%
2 Technology 13%
3 Healthcare 12.38%
4 Industrials 11.29%
5 Consumer Discretionary 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBQ
3626
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
$70K ﹤0.01%
14,087
+664
+5% +$3.29K
MARA icon
3627
Marathon Digital Holdings
MARA
$4.62B
$69K ﹤0.01%
2,515
+488
+24% +$16K
MMAT
3628
DELISTED
Meta Materials Inc. Common Stock
MMAT
$69K ﹤0.01%
293
+65
+29% +$13.5K
PRSS
3629
DELISTED
CafePress Inc.
PRSS
$69K ﹤0.01%
23,346
+752
+3% +$2.27K
VTNR
3630
DELISTED
Vertex Energy, Inc
VTNR
$68K ﹤0.01%
52,263
+1,560
+3% +$1.74K
DZSI
3631
DELISTED
DZS Inc. Common Stock
DZSI
$68K ﹤0.01%
13,773
+448
+3% +$2.36K
PSTV icon
3632
Plus Therapeutics
PSTV
$26.4M
0
EMG
3633
DELISTED
Emergent Capital, Inc.
EMG
$67K ﹤0.01%
55,620
+2,108
+4% +$4.3K
CMCT
3634
Creative Media & Community Trust
CMCT
$8.25M
0
KSPN
3635
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$66K ﹤0.01%
1,011
+27
+3% +$1.92K
ATXS
3636
DELISTED
Astria Therapeutics
ATXS
$65K ﹤0.01%
302
+12
+4% +$2.94K
IMI
3637
DELISTED
Intermolecular, Inc.
IMI
$64K ﹤0.01%
67,667
+2,228
+3% +$2.19K
EVOK
3638
DELISTED
Evoke Pharma
EVOK
$63K ﹤0.01%
216
+31
+17% +$8.03K
SBBP
3639
DELISTED
Strongbridge Biopharma plc.
SBBP
$63K ﹤0.01%
26,448
+266
+1% +$1.08K
ELMD icon
3640
Electromed
ELMD
$318M
$62K ﹤0.01%
15,869
+684
+5% +$2.83K
JYNT icon
3641
The Joint Corp
JYNT
$119M
$62K ﹤0.01%
23,352
+752
+3% +$1.84K
CPRX
3642
DELISTED
Catalyst Pharmaceutical
CPRX
$61K ﹤0.01%
58,345
+12,960
+29% +$14.8K
SIF icon
3643
SIFCO Industries
SIF
$163M
$61K ﹤0.01%
7,962
+74
+0.9% +$695
LMST
3644
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
$61K ﹤0.01%
4,958
+143
+3% +$1.45K
CDNA icon
3645
CareDx
CDNA
$1.92B
$60K ﹤0.01%
22,276
+742
+3% +$2.57K
SYRE icon
3646
Spyre Therapeutics
SYRE
$8.87B
$60K ﹤0.01%
552
+26
+5% +$3.79K
NADL
3647
DELISTED
North Atlantic Drilling Ltd
NADL
$60K ﹤0.01%
19,008
+192
+1% +$581
ACHV icon
3648
Achieve Life Sciences
ACHV
$626M
$59K ﹤0.01%
54
+12
+29% +$11.9K
ASTC icon
3649
Astrotech Corp
ASTC
$14.5M
$59K ﹤0.01%
263
+9
+4% +$2.19K
QUMU
3650
DELISTED
Qumu Corp.
QUMU
$59K ﹤0.01%
24,748
+758
+3% +$2.17K

Similar funds

BlackRock Fund Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, BlackRock Fund Advisors held 4,347 positions worth $542B, up 11% from $487B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

BlackRock Fund Advisors deployed $36.6B of net new capital in Q4 2016, opening 61 new positions and adding to 3,508 existing holdings. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 8,312,349 shares worth $426M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Russell 1000 ETF, an estimated $669M trimmed.

  • BlackRock Fund Advisors's largest Q4 2016 buy was iShares Core S&P Total US Stock Market ETF: 8,312,349 shares worth $426M.
  • BlackRock Fund Advisors added most to Apple in Q4 2016, an estimated $648M increase.
  • BlackRock Fund Advisors's biggest Q4 2016 reduction was iShares Russell 1000 ETF, cutting an estimated $669M.
  • BlackRock Fund Advisors fully exited iShares International Developed Real Estate ETF in Q4 2016, selling an estimated $317M.
  • BlackRock Fund Advisors's ten largest holdings make up 9.6% of its $542B portfolio in Q4 2016.
  • BlackRock Fund Advisors opened 61 new positions and closed 93 in Q4 2016.
  • BlackRock Fund Advisors's portfolio value rose 11% quarter-over-quarter to $542B.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.